The U.S. Food and Drug Administration (FDA) has put a cannabis-derived pain medication on the fast track for approval.
Fast track status means a drug candidate has more access to the FDA to help expedite its development, review and potential approval.
It’s the latest sign that the federal government is thawing its position on marijuana, which is still illegal under federal law. U.S. Attorney General Eric Holder has signaled that he won’t interfere with the legal recreational marijuana markets…
↧